Literature DB >> 21398323

Unusual morphological features of uterine leiomyomas treated with progestogens.

Clinton Boyd1, W Glenn McCluggage.   

Abstract

BACKGROUND: Uterine leiomyomas are extremely common in surgical pathology practice and in the vast majority there are no issues in diagnosis. Progestogens are widely prescribed drugs for a variety of indications, including abnormal uterine bleeding, and are often given to women with leiomyomas but the pathological features of leiomyomas treated with progestogens are poorly described.
METHODS: We report the pathological features in eight cases of uterine leiomyomas in women who had been treated with oral progestogens or a progestogen-containing intrauterine device; all cases were received in consultation because the features raised concern for leiomyosarcoma, smooth muscle tumour of uncertain malignant potential or a benign leiomyoma with unusual features. Additionally, we reviewed a series of cases of uterine leiomyomas (n=99) in women who exhibited progestogenic effects in the endometrium.
RESULTS: The morphological features in the consult cases, which were widespread and marked and which varied somewhat from case to case, included small and/or large areas of infarct-type necrosis (sometimes mimicking coagulative tumour cell necrosis) with surrounding increased cellularity, mitotic activity, nuclear pyknosis, cytoplasmic eosinophilia, epithelioid morphology, stromal oedema, haemorrhage, and myxoid change and infiltration by CD56 positive granulated lymphocytes. Sometimes the features resulted in an almost deciduoid appearance. Similar features were present to a minor degree in significant numbers of the additional series of cases.
CONCLUSIONS: Pathologists should be aware of these progestogen-associated features when reporting uterine leiomyomas whether or not the clinician has indicated that the woman is taking progestogens since otherwise a diagnosis of leiomyosarcoma or smooth muscle tumour of uncertain malignant potential may be rendered. Useful features in suggesting a benign leiomyoma, in addition to recognition of the morphological features described which, in combination, are characteristic of progestogens, are the lack of true nuclear atypia and the low mitotic activity away from the abnormal areas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398323     DOI: 10.1136/jcp.2011.089664

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  [Myxoid alteration of a cervical stroma cells. Mimicry of a tumor].

Authors:  J Placke; D Schmidt
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

Review 2.  [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].

Authors:  S F Lax
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

3.  Apoplectic leiomyomas: does ethnicity make a difference? a clinicopathologic study.

Authors:  Bradley M Turner; Stewart F Cramer; Debra S Heller; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2021-11-02       Impact factor: 4.064

Review 4.  Pharmacological treatment of uterine fibroids.

Authors:  Rm Moroni; Cs Vieira; Ra Ferriani; Fj Candido-Dos-Reis; Lgo Brito
Journal:  Ann Med Health Sci Res       Date:  2014-09

Review 5.  Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review.

Authors:  Jacques Donnez
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.